Robert F. Kennedy Jr.'s nomination for Health and Human Services (HHS) secretary cleared a key Senate committee today. Should ...
Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...
Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth." This interview was recorded on Jan. 15, 2024, at the World Economic Forum meeting ...
In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...
The pharma executive is optimistic about the new US administration but is also realistic about the risks that come with "radical change." ...
SAN FRANCISCO — At the end of a roundtable lunch with a group of reporters, Pfizer CEO Albert Bourla became impassioned. He admitted that after the company made a “big miscalculation” around ...
Dr. Albert Bourla is also troubled by this trend — and few people are more personally connected to the topic. Bourla is the son of two Holocaust survivors, and he is the CEO and chairman of ...
Chief Executive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. Bourla said the experts were helping Pfizer "make better and more sound decisions," and the company ...
Jim Cramer on Pfizer Inc. (PFE) CEO Albert Bourla: ‘President-elect Trump Felt That Bourla Was A Hero During COVID’ Ramish Cheema Tue, Jan 14, 2025, 3:20 PM 7 min read ...
Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...
(Bloomberg) -- Pfizer Inc. Chief Executive Officer Albert Bourla said he ... they released a statement in support of Bourla. Bourla said in the interview that Pfizer had done nothing ...
Pfizer’s CEO reflects on a year of discovery and what he thinks critics get wrong about vaccine pricing Albert Bourla talks about his employees' effort to develop a COVID-19 vaccine in record ...